This bill would require infant formula manufacturers to conduct standardized testing for specific pathogens and microorganisms in both their facilities and finished products. It mandates that companies report positive test results to the FDA within one business day and retain records of these findings for inspections. The legislation also requires the FDA to notify congressional committees within one business day of receiving positive test results or issuing certain inspection classifications. Additionally, the bill establishes clear inspection standards that apply to all infant formula products regardless of where they are made.
This bill, known as the Care Over Profits Act of 2026, aims to reform health insurance regulations by increasing the minimum medical loss ratio requirement and strengthening penalties for fraudulent enrollment practices. It directly affects health insurance companies offering plans in small group and individual markets, as well as agents and brokers who help people enroll in qualified health plans through health insurance exchanges. The bill raises the medical loss ratio requirement from 80% to 85% starting in 2026, meaning insurers must spend at least 85 cents of every premium dollar on medical care rather than administrative costs or profits. Additionally, it introduces new civil and criminal penalties for agents and brokers who negligently or knowingly provide false information during enrollment applications, with fines ranging from $10,000 to $200,000 per affected individual and potential imprisonment of up to 10 years for willful violations.
This concurrent resolution directs the President to terminate the use of U.S. Armed Forces from hostilities against Iran or any part of the Iranian government or military unless a declaration of war or authorization to use military force for such purpose has been enacted. The resolution specifies that it shall not be construed to prevent the United States from defending itself from imminent attack.
HRES 1109 is a symbolic resolution supporting National Women and Girls HIV/AIDS Awareness Day, observed annually on March 10. It recognizes the disproportionate impact of HIV/AIDS on women and girls in the U.S., particularly women of color who face higher infection rates and barriers to care. The resolution calls for increased investment in prevention, treatment, and education programs to reduce new infections and address health disparities, while emphasizing the need for culturally responsive services and comprehensive sexual health education. It does not create new laws or funding but expresses congressional support for ongoing efforts to end the HIV epidemic among women and girls.
HRES 1107 is a House resolution urging the President to issue a proclamation flying the U.S. flag at half-staff to honor Rev. Jesse Jackson. The resolution recognizes his civil rights leadership, including founding the Rainbow PUSH Coalition and his presidential campaigns in 1984 and 1988, which advanced racial equality and economic justice. This symbolic gesture directly affects the President (as the one who would issue the proclamation) and the public, who would observe the flag at half-staff.
The Supplemental Security Income Restoration Act of 2026 updates eligibility rules and benefit amounts for the Supplemental Security Income (SSI) program, which provides financial assistance to low-income individuals with limited resources. The bill increases income and resource limits for SSI recipients, exempts certain retirement accounts and tribal welfare payments from counting toward eligibility limits, and extends the SSI program to U.S. territories including Puerto Rico, the U.S. Virgin Islands, Guam, and American Samoa. Additionally, the legislation repeals a marriage penalty that previously reduced benefits for married couples and clarifies how various state tax credits and in-kind support are treated when determining eligibility.
This bill, titled the No Getting Rich in Congress Act, establishes new ethics rules for Members of Congress, their spouses, and dependents to prevent conflicts of interest and financial conflicts. It prohibits Members and their families from trading certain investments like digital assets and derivatives unless held in a blind trust, while also banning former Members and those appointed to Senate-confirmed positions from lobbying specific foreign countries after leaving office. Additionally, the bill requires spouses of senior federal officials to register and disclose lobbying activities, prohibits Members and their spouses from serving on corporate boards, and expands gift disclosure rules to include spouses as covered relatives.
HR 7827 restricts the Department of Defense from purchasing or selling military-style assault weapons and certain high-capacity ammunition (like .223 Remington) in commercial markets. It imposes strict requirements on dealers selling firearms or ammunition, including mandatory NICS background checks, limits on high-volume sales, security measures (like surveillance systems), and electronic recordkeeping for transactions. Dealers must also meet crime trace limits (fewer than 24 crime guns traced annually) and implement training on recognizing straw purchases and preventing illegal sales. Government-owned weapons plants must annually report commercial sales data to Congress, including customer locations and revenue.
This bill, titled the Medicines for the People Act, would create a new National Institute for Biomedical Research and Development within the Public Health Service Act. The new institute would conduct full-cycle research and development of drugs, devices, and biological products using federal laboratories, contracts with public and private entities, and acquisitions of existing technologies. Key provisions include government ownership of patents and trade secrets from institute-funded research, mandatory sharing of clinical trial data with the public, and licensing agreements that prioritize nonprofit and public entities while allowing some for-profit licensing under public interest terms. The institute would be overseen by a 15-member governing board with restrictions on members from the pharmaceutical industry, and it would receive an initial authorization of $90 billion for fiscal year 2027.
This bill establishes the United States Immigration Courts as an independent judicial system under Article I of the Constitution, separate from the executive branch. It creates three divisions (appellate, trial, and administrative), sets qualifications for judges, and defines jurisdiction for immigration proceedings. The bill transfers functions from the Executive Office for Immigration Review to this new court system, with detailed provisions for appointment, compensation, and retirement of judges. It also requires annual reporting to Congress on court workload and outcomes, including demographic information and case processing times.
This bill, the PrEP Access and Coverage Act of 2026, requires most health insurance plans to cover HIV prevention medication without charging patients any out-of-pocket costs. It directly affects people with private insurance, government health programs like Medicare and Medicaid, military health care, and the Indian Health Service. The law mandates that insurance companies cannot require pre-approval for these medications, cannot charge deductibles or copayments for them, and cannot deny or charge higher premiums for life, disability, or long-term care insurance based on someone taking HIV prevention medication. The bill also creates a new public education campaign to increase awareness about HIV prevention options and provides federal funding to states and community organizations to expand access to these services.
This bill requires hospitals receiving Medicare funding to create discharge plans for pregnant patients who are expected to leave the hospital before delivery, ensuring they have safe transportation and access to backup care if needed. The discharge plans must include clinical justification for early discharge, assessment of travel logistics, identification of alternative delivery facilities, and confirmation that patients understand the information in their primary language. Additionally, the bill expands rural maternal health training grants to include racial bias training, establishes performance milestones for grant recipients, and creates a new initiative to evaluate different training models for healthcare professionals. The legislation also mandates the development of a public dashboard tracking maternal health outcomes and federal investments in maternal health research.
